compound glp-1 fda Compounding: When Innovation May Mean Liability What Changed? The FDA's Clarification

A new study shows that patients with type 2 diabetes who are taking GLP-1 receptor agonists may be at an increased risk for serious vision problems, including NAION

Nutritional evaluation of protein hydrolysate formulas

Pang J, Feng JN, Ling W, Jin T (2022) The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-therapeutic potential exploration in lung injury

The element is reclassified from toxin to required trace nutrient

The benefits of creatine are well established, but the sheer number of types, forms, and brands on the market can make it difficult to pick out which is most suitable for your fitness goals and your money